253
Views
15
CrossRef citations to date
0
Altmetric
Opening lecture

The diflunisal trial: update on study drug tolerance and disease progression

, , , , , , , , , , , , , & show all
Pages 196-197 | Published online: 18 Aug 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Catarina Falcão de Campos & Isabel Conceição. (2023) Updated Evaluation of the Safety, Efficacy and Tolerability of Tafamidis in the Treatment of Hereditary Transthyretin Amyloid Polyneuropathy. Drug, Healthcare and Patient Safety 15, pages 51-62.
Read now
Yukio Ando, David Adams, Merrill D. Benson, John L. Berk, Violaine Planté-Bordeneuve, Teresa Coelho, Isabel Conceição, Bo-Göran Ericzon, Laura Obici, Claudio Rapezzi, Yoshiki Sekijima, Mitsuharu Ueda, Giovanni Palladini & Giampaolo Merlini. (2022) Guidelines and new directions in the therapy and monitoring of ATTRv amyloidosis. Amyloid 29:3, pages 143-155.
Read now

Articles from other publishers (13)

Nikita Jhawar, Juan Carlos Leoni Moreno & Razvan Chirila. (2023) A review of transthyretin cardiac amyloidosis. Romanian Journal of Internal Medicine 61:1, pages 28-34.
Crossref
Anna Cantone, Federico Sanguettoli, Beatrice Dal Passo, Matteo Serenelli & Claudio Rapezzi. (2022) The treatment of amyloidosis is being refined. European Heart Journal Supplements 24:Supplement_I, pages I131-I138.
Crossref
Augustus Hough, Jessica Wearden, Kristen de Almeida & Stephanie Kaiser. (2020) Review of Transthyretin Silencers, Stabilizers, and Fibril Removal Agents in the Treatment of Transthyretin Cardiac Amyloid. Current Cardiology Reports 22:10.
Crossref
Francesca Magrinelli, Gian Maria Fabrizi, Lucio Santoro, Fiore Manganelli, Giampietro Zanette, Tiziana Cavallaro & Stefano Tamburin. (2020) Pharmacological treatment for familial amyloid polyneuropathy. Cochrane Database of Systematic Reviews.
Crossref
Elissa Driggin & Mathew S. Maurer. (2019) The quintessential form of diastolic heart failure in older adults: Wild type transthyretin cardiac amyloidosis. Clinical Cardiology 43:2, pages 171-178.
Crossref
Gil Yong Park, Angelo Jamerlan, Kyu Hwan Shim & Seong Soo A. An. (2019) Diagnostic and Treatment Approaches Involving Transthyretin in Amyloidogenic Diseases. International Journal of Molecular Sciences 20:12, pages 2982.
Crossref
Hannah RosenblumAdam CastanoJulissa AlvarezJeff GoldsmithStephen HelmkeMathew S. Maurer. (2018) TTR (Transthyretin) Stabilizers Are Associated With Improved Survival in Patients With TTR Cardiac Amyloidosis. Circulation: Heart Failure 11:4.
Crossref
Kenneth Varian & W. H. Wilson Tang. (2017) Therapeutic Strategies Targeting Inherited Cardiomyopathies. Current Heart Failure Reports 14:4, pages 321-330.
Crossref
Márcia Waddington Cruz & Merril D. Benson. (2015) A Review of Tafamidis for the Treatment of Transthyretin-Related Amyloidosis. Neurology and Therapy 4:2, pages 61-79.
Crossref
Mariëlle H. J. Pruppers, Ingemar S. J. Merkies, Catharina G. Faber, Ana M. Da Silva, Vanessa Costa & Teresa Coelho. (2015) The Val30Met familial amyloid polyneuropathy specific Rasch-built overall disability scale (FAP-RODS © ) . Journal of the Peripheral Nervous System 20:3, pages 319-327.
Crossref
David Adams. (2012) Recent advances in the treatment of familial amyloid polyneuropathy. Therapeutic Advances in Neurological Disorders 6:2, pages 129-139.
Crossref
Susan C. Shin & Jessica Robinson‐Papp. (2012) Amyloid Neuropathies. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 79:6, pages 733-748.
Crossref
Joel N. Buxbaum & Reinhold P. Linke. (2012) A Molecular History of the Amyloidoses. Journal of Molecular Biology 421:2-3, pages 142-159.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.